| Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... The lancet Diabetes & endocrinology 9 (2), 82-93, 2021 | 326 | 2021 |
| N-glycan profile and kidney disease in type 1 diabetes ML Bermingham, M Colombo, SJ McGurnaghan, LAK Blackbourn, ... Diabetes care 41 (1), 79-87, 2018 | 102 | 2018 |
| Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications A Jeyam, H Colhoun, S McGurnaghan, L Blackbourn, TJ McDonald, ... Diabetes Care 44 (2), 390-398, 2021 | 79 | 2021 |
| Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis S McGurnaghan, LAK Blackbourn, E Mocevic, U Haagen Panton, ... Diabetic Medicine 36 (6), 718-725, 2019 | 70 | 2019 |
| Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland PM McKeigue, S McGurnaghan, L Blackbourn, LE Bath, DA McAllister, ... Diabetes care 46 (5), 921-928, 2023 | 64 | 2023 |
| Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016 C Mair, W Wulaningsih, A Jeyam, S McGurnaghan, L Blackbourn, ... Diabetologia 62, 1375-1384, 2019 | 55 | 2019 |
| Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group. Risks of and risk factors for COVID-19 disease in people … SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... Lancet Diabetes Endocrinol 9 (2), 82-93, 2021 | 49 | 2021 |
| Persistent C-peptide secretion in type 1 diabetes and its relationship to the genetic architecture of diabetes PM McKeigue, A Spiliopoulou, S McGurnaghan, M Colombo, ... BMC medicine 17, 1-11, 2019 | 49 | 2019 |
| The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study SJ McGurnaghan, L Brierley, TM Caparrotta, PM McKeigue, ... Diabetologia 62, 621-632, 2019 | 41 | 2019 |
| Biomarker panels associated with progression of renal disease in type 1 diabetes M Colombo, E Valo, SJ McGurnaghan, N Sandholm, LAK Blackbourn, ... Diabetologia 62, 1616-1627, 2019 | 40 | 2019 |
| Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes M Colombo, SJ McGurnaghan, LAK Blackbourn, RN Dalton, D Dunger, ... Diabetologia 63, 788-798, 2020 | 38 | 2020 |
| Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from … A Jeyam, SJ McGurnaghan, LAK Blackbourn, JM McKnight, F Green, ... Diabetes Care 43 (4), 734-742, 2020 | 36 | 2020 |
| Development and validation of a cardiovascular risk prediction model in type 1 diabetes SJ McGurnaghan, PM McKeigue, SH Read, S Franzen, AM Svensson, ... Diabetologia 64 (9), 2001-2011, 2021 | 25 | 2021 |
| Risks of and risk factors for COVID‑19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021; 9 (2): 82–93 SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... Diabetes Res Clin Pract 167, 108354, 2020 | 24 | 2020 |
| Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland A Jeyam, FW Gibb, JA McKnight, B Kennon, JE O’Reilly, TM Caparrotta, ... Diabetologia 64, 1320-1331, 2021 | 22 | 2021 |
| Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide … A Jeyam, FW Gibb, JA McKnight, JE O’Reilly, TM Caparrotta, A Höhn, ... Diabetologia 65, 159-172, 2022 | 21 | 2022 |
| Effect of serum sample storage temperature on metabolomic and proteomic biomarkers E Valo, M Colombo, N Sandholm, SJ McGurnaghan, LAK Blackbourn, ... Scientific Reports 12 (1), 4571, 2022 | 15 | 2022 |
| Prescribing paradigm shift? Applying the 2019 European Society of Cardiology–led guidelines on diabetes, prediabetes, and cardiovascular disease to assess eligibility for … TM Caparrotta, LAK Blackbourn, SJ McGurnaghan, J Chalmers, ... Diabetes Care 43 (9), 2034-2041, 2020 | 15 | 2020 |
| Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017 JE O’Reilly, LAK Blackbourn, TM Caparrotta, A Jeyam, B Kennon, ... Diabetologia 63, 1626-1636, 2020 | 15 | 2020 |
| Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in Scotland: a nationwide retrospective cohort observational study JE O’Reilly, A Jeyam, TM Caparrotta, J Mellor, A Hohn, PM McKeigue, ... Diabetes Care 44 (9), 2010-2017, 2021 | 13 | 2021 |
